Ascend Therapeutics
Focus: Ascend Therapeutics is a specialty pharmaceutical company focused on women's health and niche therapeutic areas, operating at mid-market scale (1,001-5,000 employees) with a diverse portfolio spanning hormonal therapies, rare diseases, and oncology.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Employees
1001-5000
Open Jobs
0
About Ascend Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Ascend Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
13 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$1M Part DDeclining
LOE Approaching
Sole revenue driver (100% of revenue) despite modest Part D spending, creating urgent need for pipeline transition.
Help build intelligence for Ascend Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.